Analysts Set National Health Investors, Inc. (NYSE:NHI) Price Target at $62.13

Shares of National Health Investors, Inc. (NYSE:NHI) have been given a consensus rating of “Moderate Buy” by the eight brokerages that are covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $62.13.

A number of equities analysts recently commented on the stock. Truist Financial lifted their price target on shares of National Health Investors from $58.00 to $65.00 and gave the stock a “hold” rating in a research note on Wednesday, June 26th. Wells Fargo & Company boosted their target price on National Health Investors from $63.00 to $69.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Finally, StockNews.com upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Thursday, August 8th.

National Health Investors Trading Up 0.2 %

Shares of NHI stock opened at $74.59 on Friday. The company has a market cap of $3.24 billion, a PE ratio of 24.46 and a beta of 1.02. National Health Investors has a 1 year low of $48.51 and a 1 year high of $76.65. The stock’s 50 day simple moving average is $70.55 and its two-hundred day simple moving average is $63.93. The company has a debt-to-equity ratio of 0.91, a current ratio of 13.24 and a quick ratio of 13.24.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, August 6th. The real estate investment trust reported $0.81 earnings per share for the quarter, missing the consensus estimate of $1.10 by ($0.29). The company had revenue of $84.97 million for the quarter, compared to the consensus estimate of $64.95 million. National Health Investors had a net margin of 41.40% and a return on equity of 10.41%. The business’s revenue for the quarter was up 9.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.06 EPS. Research analysts predict that National Health Investors will post 4.4 earnings per share for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Friday, September 27th will be paid a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 4.83%. The ex-dividend date of this dividend is Friday, September 27th. National Health Investors’s dividend payout ratio is presently 118.03%.

Insider Activity at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 437 shares of the firm’s stock in a transaction on Friday, May 31st. The stock was acquired at an average cost of $65.83 per share, with a total value of $28,767.71. Following the transaction, the director now directly owns 21,585 shares in the company, valued at approximately $1,420,940.55. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 7.26% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Strategic Financial Concepts LLC purchased a new stake in shares of National Health Investors in the 2nd quarter worth approximately $28,000. Compass Wealth Management LLC bought a new position in National Health Investors in the first quarter worth approximately $30,000. International Assets Investment Management LLC purchased a new stake in National Health Investors during the second quarter worth $36,000. Baystate Wealth Management LLC bought a new stake in National Health Investors during the 4th quarter valued at $39,000. Finally, Blue Trust Inc. increased its holdings in shares of National Health Investors by 2,651.9% in the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 716 shares during the period. 62.51% of the stock is currently owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.